BCM
TEVA icon

BBT Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

BBT Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-100,000
Closed -$5.28M – 271
2014
Q1 		$5.28M Hold
100,000
– – 0.24% 106
2013
Q4 		$4.01M Buy
+100,000
New +$3.94M 0.18% 136

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BBT Capital Management's TEVA Position: Q4 2015 in Review

BBT Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2015, closing a stake of 4,143 shares — an estimated $234K sold.

BBT Capital Management first reported a position in TEVA in Q4 2013 and held it in 5 quarters. The position peaked at $2.75M in Q4 2013. 877 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

  • BBT Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2015 after selling out during the quarter.
  • BBT Capital Management sold 4,143 Teva Pharmaceutical Industries Limited shares in Q4 2015, an estimated $234K.
  • BBT Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 5 quarters.
  • BBT Capital Management's Teva Pharmaceutical Industries Limited position peaked at $2.75M in Q4 2013.
  • 877 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2015.

Based on BBT Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.